WallStreetZenWallStreetZen

NASDAQ: BNTC
Benitec Biopharma Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Benitec Biopharma earnings were -$48.9M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest BNTC earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$11.9M, up 0.8% from last quarter. For the last reported fiscal year 2025 ending Jun 30, 2025, BNTC reported annual earnings of -$37.9M, with 69.5% growth. The next BNTC earnings date is Sep 22, 2026.

BNTC earnings history

Current Revenue
$0.0
Current Earnings
-$48.9M
Current Profit Margin
0%

BNTC Return on Equity

Current Company
-34.8%
Current Industry
-141.9%
Current Market
13.5%
BNTC's Return on Equity (-34.8%)... subscribe to Premium to read more.
High Return on Equity Performance

BNTC Return on Assets

Current Company
-34.1%
Current Industry
-13.7%
BNTC is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when BNTC announces earnings.

BNTC Return on Capital Employed

Current Company
-26.04%
Current Industry
-9.6%
BNTC has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BNTC vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
BNTC-$47.37M-$48.88MN/A-$0.01
PBYI$44.99M$24.38M+158.74%$0.50
HELP-$104.14M-$104.22MN/A-$2.99
STRO-$140.80M-$153.60MN/A-$16.43
EVMNN/AN/AN/AN/A
View Top Biotech Stocks

BNTC earnings dates

Next earnings date
Sep 22, 2026

Benitec Biopharma Earnings Reports & History FAQ

What were Benitec Biopharma's earnings last quarter?

Benitec Biopharma (NASDAQ: BNTC) reported Q1 2026 earnings per share (EPS) of -$0.00, up 50% year over year. Total BNTC earnings for the quarter were -$11.94 million. In the same quarter last year, Benitec Biopharma's earnings per share (EPS) was -$0.00.

If you're new to stock investing, here's how to buy Benitec Biopharma stock.

When does Benitec Biopharma report earnings?

The next BNTC earnings call is Sep 22, 2026. Add BNTC to your watchlist to be reminded of Benitec Biopharma's next earnings date.

Is Benitec Biopharma profitable or losing money?

As of the last Benitec Biopharma earnings report, Benitec Biopharma is currently losing money. Benitec Biopharma's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$48.88 million, a 44.49% increase year over year.

What was BNTC's earnings growth in the past year?

As of Benitec Biopharma's earnings date in Q3 2026, Benitec Biopharma's earnings has grown year over year. BNTC earnings in the past year totalled -$48.88 million.

What are Benitec Biopharma's earnings expectations?

The current EPS estimate for Benitec Biopharma's earnings report in Sep 22, 2026 is -$0.28.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.